EP 3390619 A1 20181024 - THERAPEUTIC T CELLS
Title (en)
THERAPEUTIC T CELLS
Title (de)
THERAPEUTISCHE T-ZELLEN
Title (fr)
LYMPHOCYTES T THÉRAPEUTIQUES
Publication
Application
Priority
- GB 201522223 A 20151216
- GB 2016053951 W 20161215
Abstract (en)
[origin: WO2017103598A1] Use of C-X-C chemokine receptor type 4 (CXCR4) for increasing the capacity for self- renewal and/or persistence in a T cell; increasing the capacity for engraftment in a T cell; and/or increasing the memory function of a T cell.
IPC 8 full level
C12N 5/0783 (2010.01); A61K 35/17 (2015.01); C07K 14/715 (2006.01)
CPC (source: EP US)
A61K 38/1793 (2013.01 - EP US); A61K 39/4611 (2023.05 - EP US); A61K 39/464402 (2023.05 - EP US); A61K 2239/31 (2023.05 - US); A61K 2239/38 (2023.05 - US); A61K 2239/48 (2023.05 - US); A61P 35/00 (2018.01 - EP US); C07K 14/7158 (2013.01 - EP US); C12N 5/0636 (2013.01 - EP US); A61K 2239/31 (2023.05 - EP); A61K 2239/38 (2023.05 - EP); A61K 2239/48 (2023.05 - EP); C12N 2501/21 (2013.01 - EP US); C12N 2510/00 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017103598 A1 20170622; CN 108603172 A 20180928; EP 3390619 A1 20181024; GB 201522223 D0 20160127; US 2018371412 A1 20181227
DOCDB simple family (application)
GB 2016053951 W 20161215; CN 201680080364 A 20161215; EP 16816353 A 20161215; GB 201522223 A 20151216; US 201616062590 A 20161215